107 
J&J, Legend cell therapy approved by FDA for multiple myeloma
Bio Pharma Dive
FEBRUARY 28, 2022
The CAR-T treatment is the second to be approved in the U.S. for the blood cancer, following Bristol Myers Squibb and 2Seventy bio's Abecma
February, 2022
Lung cancer deaths decline but.
World of DTC Marketing
FEBRUARY 17, 2022
The mortality rate from lung cancer has dropped in recent decades—by 56% in men from 1990 to 2019 and by 32% in women from 2002 to 2019. In recent years, early detection and treatment improvements have helped boost the 3-year survival rate for lung cancer from 21% in 2004 to 31% in 2015 through 2017.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Simons Foundation gives $4 million to CUNY Graduate Center to diversify astrophysics education
Scienmag
FEBRUARY 9, 2022
NEW YORK, February 9, 2022– Astrophysics is one of the most popular science fields, igniting the imaginations of many as they learn about it from television shows or news of space exploration. Like many other STEM fields, though, it lags in attracting students of color.
Top 3 Things to Know About Engaging Oncologists in 2022
Pharma Marketing Network
FEBRUARY 10, 2022
Experts from top life sciences companies discussed strategies for more effectively engaging oncologists at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about engaging oncologists in 2022: 1. Lead with clinical education.
2022 Research: The Rapid Rise of Ocean Freight Visibility
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Pharma Franchise Business Is Beneficial For the Indian Pharmaceutical Market
Fossil Remedies
FEBRUARY 18, 2022
PCD Pharma Franchise Business. Why are more aspirants willing to make a career in the field of pharmaceuticals? It is because the business is not only promising, but it is going to remain profitable for many years. People have become health conscious and they want to maintain fitness.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
|
More Trending
'The music stopped': Biotech rout leaves drug startups grounded as demand slumps for IPOs
Bio Pharma Dive
FEBRUARY 6, 2022
For the first time in years, biotechs no longer have an easy path onto Wall Street, a market reversal that could change what the next generation of young drugmakers looks like
Biogen continues to sink
World of DTC Marketing
FEBRUARY 7, 2022
Board members and senior executives are bailing out of Biogen but will there be enough life vests? What has/is happening at Biogen is a train wreck, and the only way to correct this disaster is to tear it down and rebuild the company from the top down.
Your microbiome shapes your life. But where did it come from?
Scienmag
FEBRUARY 9, 2022
Baltimore, MD— The gut microbiome is an ecosystem of hundreds to thousands of microbial species living within the human body. These populations affect our health, fertility, and even our longevity. But how do they get there in the first place?
J.&J. Pauses Production of Its Covid Vaccine Despite Persistent Need
NY Times
FEBRUARY 8, 2022
A crucial Johnson & Johnson plant has stopped making its Covid vaccine, though the company says it has millions of doses in inventory. Vaccination and Immunization Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Factories and Manufacturing Johnson & Johnson
An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Intellia presses forward with new results for pioneering CRISPR drug
Bio Pharma Dive
FEBRUARY 28, 2022
The findings build on early evidence that gene editing inside the body could safely and effectively treat disease, and suggest the effects of Intellia's medicine might last
AI-powered stethoscope from Eko spots heart failure in seconds
Pharma Phorum
FEBRUARY 1, 2022
A study has shown that a ‘smart’ stethoscope developed by US digital health company Eko can be used to screen people for heart failure in a few second during a standard physical examination.
BioMarin says gene therapy hold will endure as FDA questions cancer risk
Bio Pharma Dive
FEBRUARY 18, 2022
According to BioMarin, the regulator has requested additional data to assess the "theoretical" cancer risk to the treatment, information that will take "several quarters" to collect
When it comes to telehealth it’s not numbers
World of DTC Marketing
FEBRUARY 18, 2022
Business Insider formed a relationship with eMarketer for so-called “intelligence.” ” Their report on telehealth has numbers, but that’s not what’s important.
Mandatory COVID Vaccination Policy Template
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
NJIT reaffirmed as an elite research university, retains R1 classification
Scienmag
FEBRUARY 3, 2022
New Jersey Institute of Technology (NJIT) has reaffirmed its status among the nation’s most elite and productive research institutions by once again achieving an R1 status — the highest designation — by the Carnegie Classification.
Moderna targets shingles in mRNA pipeline expansion
BioPharma Reporter
FEBRUARY 21, 2022
Moderna is expanding its mRNA pipeline with three new development programs: with vaccine candidates against herpes simplex virus (HSV), varicella-zoster virus (VSV) and a new checkpoint cancer vaccine. Bio Developments
FDA sends signal with tough questions of Lilly at cancer drug meeting
Bio Pharma Dive
FEBRUARY 10, 2022
The agency criticized Eli Lilly for using a trial run in China to seek approval of an immunotherapy it licensed from Innovent Biologics. Outside advisers agreed in a decisive vote that could have repercussions for several other drugmakers
Brain activity study backs Akili’s digital therapy for ADHD
Pharma Phorum
FEBRUARY 17, 2022
Akili Interactive’s prescription gaming app for attention deficit hyperactivity disorder (ADHD) EndeavorRx has been show to enhance neuronal activity in an area of the brain associated with attention function.
Yumanity cutting 60% of employees as it mulls possible sale
Bio Pharma Dive
FEBRUARY 17, 2022
The layoffs — which, according to Yumanity, should be completed by April — are part of a larger restructuring effort meant to reduce costs after a recent setback to the company's most advanced drug program
How agencies can help pharma DTC
World of DTC Marketing
FEBRUARY 3, 2022
The way people make treatment decisions is changing because of COVID. Agencies are responsible for working with clients to implement changes that support brand objectives. It won’t be easy and means changing the mindset from a vendor to a strategic partner.
Even the smallest pollution particles change the rainfall regime in the Amazon
Scienmag
FEBRUARY 4, 2022
Even the finest particles of pollution influence the process of cloud formation and the rainfall regime.
Plant-based COVID-19 vaccine approved in Canada
BioPharma Reporter
FEBRUARY 28, 2022
Medicago and GlaxoSmithKline (GSK) have gained approval for Covifenz, the companiesâ plant-based COVID-19 vaccine, from Health Canada. Markets & Regulations
Sarepta reveals gene editing alliance with biotech exploring alternative delivery methods
Bio Pharma Dive
FEBRUARY 1, 2022
The collaboration with GenEdit, a South San Francisco startup developing new ways of delivering gene editing tools into the body, dates back to December 2020, but has recently begun to advance
Tackling barriers to diversity, equity, and inclusion in clinical trials
Clairnes
FEBRUARY 8, 2022
The post Tackling barriers to diversity, equity, and inclusion in clinical trials appeared first on Clinical Trial Recruitment & Management Services.
Pfizer lures research chief from Roche, prompting high-level reshuffle
Bio Pharma Dive
FEBRUARY 1, 2022
William Pao led discovery and early development at the Swiss drugmaker, and will now head Pfizer's global efforts to launch new products
Mental health apps can be useless
World of DTC Marketing
FEBRUARY 8, 2022
According to the Lancet, a medical journal, the incidence of depression and anxiety has soared in the pandemic—by more than 25% globally in 2020. That, combined with more people using online services, has led to a boom in mental-health apps. But are they safe and effective?
Coordinated conservation and restoration critical to save Asia’s threatened native trees
Scienmag
FEBRUARY 1, 2022
A new study has revealed that the rich native tree diversity in South and Southeast Asia is at risk of potential extinction.
Cancer vaccines: providing the edge in oncology
Pharma Phorum
FEBRUARY 9, 2022
In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector.
Moderna sued for allegedly infringing patents tied to COVID-19 vaccine
Bio Pharma Dive
FEBRUARY 28, 2022
Arbutus and partner Genevant claim Moderna's coronavirus shot uses delivery technology covered by six patents they hold, an allegation Moderna denies
Why the FDA is making a test case of a cancer drug from China
Bio Pharma Dive
FEBRUARY 8, 2022
In documents released Tuesday, FDA staff gave a cool review to an immunotherapy developed by Eli Lilly and Innovent Biologics. An advisory meeting this week to review it could have broader implications for cancer drug development in the U.S.
Moderna bets on booster demand, advancing new 'bivalent' COVID-19 shot
Bio Pharma Dive
FEBRUARY 24, 2022
The biotech will start trials in the U.S. and U.K. of a vaccine that targets both the original coronavirus strain and the omicron variant
Is it too late for Biogen?
World of DTC Marketing
FEBRUARY 2, 2022
Biogen will partner with Roche on the development, and potential sale of a promising cancer drug the Swiss pharma is advancing for several types of lymphoma, announcing Tuesday it’s exercised an option to share rights to the treatment.
Let's personalize your content